DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Shima M, Nanbusa H, Taki M , et al.
Long-term safety and prophylactic efficacy of once-weekly subcutaneous administration of ACE910 in Japanese hemophilia A patients with and without FVIII inhibitors: interim results of the extension study of a phase 1 study (Abstract).
J Thromb Haemost 2015;
13 (Suppl. 02) AS017
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.